Work

Corrigendum: EGLN2 attenuates ovarian cancer malignancy via ferroptosis activation

Year: 2025
Type: erratum
Abstract: These errors arose during the final manuscript preparation and production stages.The corrections are listed below for clarity:1) Location: Methods Section, subsection "Cell Lines"The following sentence has been added: "The normal human ovarian epithelial cell lines IOSE386 and IOSE80 were kindly provided by Dr. Xu Juan (Women's Hospital of Nanjing Medical University, China)." 2) Location: Figure 2Panel C, y-axis label: EdU% (中文) -corrected as "EdU Proportion" Panel C, EdU image: The published image contained an assembly error.Correction: The image has been replaced with the correctly assembled version from the original dataset to accurately represent the experimental data. 3) Location: Figure 6Panel D, EdU image: The published image contained an assembly error.Correction: The image has been replaced with the correctly assembled version from the original dataset to accurately represent the experimental data.S4 During the production process, the original Supplementary Figure S4 was erroneously replaced by a duplicate of Figure 4. Correction: Incorrectly used Figure 4 has been replaced with the original Supplementary Figure S4 corresponding to the Figure legend, supplemented with the indication of statistical significance (***).These errors have now been corrected with the appropriate Figures shown below. 4) Location: Supplementary Figure
Source: Neoplasma
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4416200294
Cites:
Cited by:
Related to: